Abstract
Serum levels of soluble interleukin-2 receptor (sIL-2R) and cancer antigen 125 (CA 125) in dogs diagnosed with cutaneous lymphoma
Highlights
SIL-2R and cancer antigen 125 (CA 125) could be used as additional non-invasive tools for tumor staging and to establish the prognosis in dogs diagnosed with cutaneous lymphoma
This study evaluated whether the serum concentrations of sIL-2R and CA 125 could be used as additional non-invasive tools for tumor staging and to establish the prognosis in dogs diagnosed with cutaneous lymphoma
For the quantitative determination of sIL-2R levels, 200μL of blood serum that was individually aliquoted from the control and cutaneous lymphoma groups was assayed using an IL-2R canine ELISA kit (MyBiosource, CA, USA), and the reading was performed using a Stat Fax 2100 microplate reader (Awareness Technology)
Summary
This study evaluated whether the serum concentrations of sIL-2R and CA 125 could be used as additional non-invasive tools for tumor staging and to establish the prognosis in dogs diagnosed with cutaneous lymphoma. The serum concentrations of sIL-2R and CA 125 were measured in the control and cutaneous lymphoma groups.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
